• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Hao Haiping, President of China Pharmaceutical University, led a team to visit Hankang Pharmaceutical Group to investigate and form a strategic cooperation framework

    PRESS RELEASE

    Longyaoxing Hankang Ningpengcheng丨Hankang Pharmaceutical Group`s 2023 Summary Commendation and 2024 New Year Annual Meeting Grand Opening

    PRESS RELEASE

    New heights and new journey: Hankang Innovative Pharmaceutical Research Company grand opening

    PRESS RELEASE

    Warm congratulations to Hankang Analysis and Testing Service Center for successfully passing the review and certification by the National CNAS Accreditation Committee

    PRESS RELEASE

    Yaotong Process Devp Several easily overlooked points in removal impurities

    PRESS RELEASE

    Hankang help customers get ampicillin sodium inj.reviewed by top 3 company China

    PRESS RELEASE

    A delegation from Tianjin Pharmaceutical visited Hankang for inveg & exchange

    PRESS RELEASE

    Go for passion and perseverance 3rd "Vibrant Hankang" concluded successfully

    PRESS RELEASE

    Hankang Pharmaceutical Group`s 2022 summary and commendation and 2023 New Year`s annual meeting successfully held

    PRESS RELEASE

    The first in the country Innovative scientific research methods to seize market advantages for customers Hankang helps high-variety allopurinol tablets

    PRESS RELEASE

    Shiyaotonghui Lida Qunying Guangzhou Huiying Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Hankang Pharmaceutical Group

    PRESS RELEASE

    The new preparation research center of Hankang Pharmaceutical Group was grandly completed to provide the pharmaceutical industry with high innovation, high intelligence and high technology

    PRESS RELEASE

    Hankang assisted Shanghai Xudong Haipu in the review haloperidol APIs &Inj

    PRESS RELEASE

    On-site project verification all passed Hankang Pharmaceutical Group

    PRESS RELEASE

    Hankang assisted torasemide injection to obtain production approval

    PRESS RELEASE

    Hankang Pharma was awarded as "Specialized, Specialized, Special and New"

    PRESS RELEASE

    Continuing to inject new kinetic energy, Hankang Pharma passed the certification

    PRESS RELEASE

    Strong skills and striving for the first-class Hankang Pharma Analysis &Research

    PRESS RELEASE

    Improve personal ability & drive team progress Hankang Group`s 360d leadership

    PRESS RELEASE

    Complementary & seek development Hankang and Yixin Group signed agreement

    PRESS RELEASE

    Tianjin Hanrui Pharmaceutical successfully passed the 2010 GMP certification

    PRESS RELEASE

    Environmental Information Publicity

    PRESS RELEASE

    Wuhan Hiteck Biological Pharma Co.,Ltd completed the acquisition of Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. from Yan Jie, Liang Yunce and GL Hacon HK Investment Limited.

    MARKET SCREENER

    The second quarter of 2016 -- the twenty-fourth issue

    PRESS RELEASE

    Environmental information disclosure

    PRESS RELEASE

    The second quarter of 2015-total twentieth issue

    PRESS RELEASE

    The third quarter of 2015-the twenty-first issue

    PRESS RELEASE

    The fourth quarter of 2015-total twenty-second issue

    PRESS RELEASE

    The first quarter of 2016-total twenty-third issue

    PRESS RELEASE

    The second quarter of 2016-the twenty-fourth issue

    PRESS RELEASE

    The third quarter of 2016-total twenty-fifth issue

    PRESS RELEASE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.